期刊文献+

基于VEGFR靶点的小分子肿瘤靶向抑制肽的99Tcm标记及鉴定 被引量:2

Radionuclide labeling of small molecular inhibitory peptides targeting VEGF receptor
下载PDF
导出
摘要 目的探讨基于血管内皮生长因子受体(vascular endothelial growth factor receptor,VEGFR)靶点的小分子肿瘤靶向抑制肽理想的放射性核素99Tcm标记方法。方法多肽QKRKRKKSRKKH、RKRKRKKSRYIVLS分别经双功能螯合剂S-acetyl-MAG3、GA(D)GG、HYNIC修饰后进行放射性核素99 Tcm标记,HPLC及纸层析法鉴定其标记率及放化纯度,3 H-TdR参入实验鉴定其抑制细胞增殖的能力,体外受体竞争结合实验鉴定其受体结合活性。结果以HYNIC为双功能螯合剂,这2条多肽的99Tcm标记率分别为(94.13±1.77)%、(93.79±3.53)%,明显高于S-acetyl-MAG3、GA(D)GG修饰多肽的标记率。经HYNIC修饰后的多肽对肿瘤细胞A549增殖的抑制率约为(32.86±3.36)%、(61.50±4.50)%,与修饰前无明显变化(P>0.05);多肽标记后仍保持了良好的VEGFR结合活性,室温下放置24 h后,放化纯度仍高达90%左右。结论以HYNIC为双功能螯合剂,以TPPTS为协同配体及还原剂,多肽QKRKRKKSRKKH、RKRKRKKSRYIVLS的99 Tcm标记率高,且仍具有良好的抑制肿瘤细胞增殖的能力和VEGFR结合活性。 Objective To investigate radionuclide labeling methods of small molecular inhibitory peptide targeting vascular endothelial growth factor receptor ( VEGF reeeptor) of tumor with 99Tcm. Methods After being modified by S-acetyl-MAG3, GA (D)GG and HYNIC respectively, QKRKRKKSRKKH and RKRKRKKSRYIVLS were labeled with 99Tcm. Labeling efficiency and radiochemical purity was identified by paper chromatography and HPLC. The inhibitory affeet of peptide to tumor eell was testified by 3 H-TdR incorpo- ration. Receptor eompetition binding assay was used to testify the affinity of peptide ligand based on A549 cells. Results The labeling efficieney of two peptide modified by three bifunctional ehelating agents was about 78%, 40% and 94% respectively. The inhibitory efficiency of HYNIC-QKRKRKKSRKKH and HYNIC-RKRKRKK- SRYIVLS to A549 cells was about (32.86 + 3.36 ) % and (61.50 + 4.50) %, and did not have statistically significant difference with QKRKRKKSRKKH and RKRKRKKSRYIVLS. Meanwhile the 99Tcm-HYNIC- QKRKRKKSRKKH and 99Tc'-HYNIC-RKRKRKKSRYIVLS retained a good stability and binding activity of VEGF receptor in A549 cells. Conclusion HYNIC-QKRKRKKSRKKH and HYNIC-RKRKRKKSRYIVLS have a high labeling efficiency with TPPTS as a redueing agent and collaborative ligand, and the labeled agents retain inhibiting aetivity and binding activity of reeeptor to A549 cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第1期24-28,共5页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(30970848) 重庆市自然科学基金(CSTC2009BB5337)~~
关键词 血管内皮生长因子 双功能螯合剂 核素标记 肿瘤显像 vascular endothelial growth factor bifunctional chelating agent radionuclide labelingtechnique tumor imaging
  • 相关文献

参考文献13

  • 1胡国栋,杨千姣,景云荣,刘丹,赵临襄.以VEGFR为靶点的小分子抗肿瘤药物的研究进展[J].中国药物化学杂志,2010,20(5):434-441. 被引量:3
  • 2Backer M V,Levashova Z,Patel V,et al.Molecular imaging of VEGFreceptors in angiogenic vasculature with single-chain VEGF-basedprobes[J].Nat Med,2007,13(4):504-509.
  • 3Ivy S P,Wick J Y,Kaufman B M.An overview of small-molecule in-hibitors of VEGFR signaling[J].Nat Rev Clin Oncol,2009,6(10):569-579.
  • 4Hsu A R,Cai W,Veeravagu A,et al.Multimodality molecular ima-ging of glioblastoma growth inhibition with vasculature-targeting fusiontoxin VEGF121/rGel[J].J Nucl Med,2007,48(3):445-454.
  • 5黄定德,李前伟,刘广元,谢赣丰,程绍钧.^(99)Tc^m标记多肽VEGF125-136及其生物学分布[J].第三军医大学学报,2007,29(17):1660-1662. 被引量:7
  • 6Rao P S,Thakur M L,Pallela V,et al.99Tcm labeled VIP analog:e-valuation for imaging colorectal cancer[J].Nucl Med Biol,2001,28(4):445-450.
  • 7靳存敬,史继云,刘妍,靳晓娜,黄金铭,赵慧云,李方,王凡.^(99)Tc^m标记的PEG_4/2PEG_4修饰的环状RGD二聚体体内外性质的对比[J].核化学与放射化学,2010,32(5):287-292. 被引量:3
  • 8Jia H,Jezequel S,Lohr M,et al.Peptides encoded by exon 6 ofVEGF inhibit endothelial cell biological responses and angiogenesis in-duced by VEGF[J].Biochem Biophys Res Commun,2001,283(1):164-173.
  • 9Qin Z X,Li Q W,Liu G Y,et al.Imaging targeted at tumor with(188)Re-labeled VEGF(189)exon 6-encoded peptide and effects ofthe transfecting truncated KDR gene in tumor-bearing nude mice[J].Nucl Med Biol,2009,36(5):535-543.
  • 10杨明福,刘广元,李前伟.^(99)Tc^m-MAG_3-K237的制备及其在健康动物体内的药代动力学和分布研究[J].第三军医大学学报,2010,32(5):482-485. 被引量:3

二级参考文献83

共引文献13

同被引文献25

  • 1Niu G,Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy[J].{H}Current Drug Targets,2010,(08):1000-1017.
  • 2Kniess T. Radiolabeled small molecule inhibitors of VEGFR-recent advances[J].{H}Current Pharmaceutical Design,2012,(20):2867-2874.
  • 3Jia H,Jezequel S,Lohr M. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF[J].{H}Biochemical and Biophysical Research Communications,2001,(01):164-173.
  • 4Qin Z X,Li Q W,Liu G Y. Imaging targeted at tumor with 188Re-labeled VEGF 189 exon 6-encoded peptide and effects of the transfecting truncated KDR gene in tumor-bearing nude mice[J].{H}Nuclear Medicine and Biollgy,2009,(05):535-543.
  • 5Das T,Banerjee S,Samuel G. 188Re-ethylene dicysteine:a novel agent for possible use in endovascular radiation therapy[J].{H}Nuclear Medicine Communications,2000,(10):939-945.
  • 6Liu G,Dou S,He J. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting[J].{H}Applied Radiation and Isotopes,2006,(09):971-978.
  • 7Dadachova E,Moadel T,Schweitzer A D. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease[J].{H}Cancer Biotherapy & Radiopharmaceuticals,2006,(02):117-129.
  • 8Yoshimura K,Minami T,Nozawa M. Phase Ⅰ clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma[J].{H}British Journal of Cancer,2013,(06):1260-1266.
  • 9Dubbelman A C,Upthagrove A,Beijnen J H. Disposition and metabolism of 14C-dovitinib (TKI258),an inhibitor of FGFR and VEGFR,after oral administration in patients with advanced solid tumors[J].{H}Cancer Chemotherapy and Pharmacology,2012,(05):653-663.
  • 10Zhao D,Jin X,Li F. Integrin αvβ3 imaging of radioactive iodine-refractory thyroid cancer using 99Tcm-3PRGD2[J].{H}Journal of Nuclear Medicine,2012,(12):1872-1877.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部